Elan chronicles

Elan chronicles

Elan's weekly stock price tracked against various restructuring-related events since the start of 2002. A. 1/17 - ELN drops 17% to $29.25 after a Wall Street Journal article raises questions about accounting practices.B. 2/7 - ELN announces that it is being investigated by the SEC. C. 6/10 - ELN says it will simplify its operations by focusing on neurology, pain management and autoimmune diseases; divesting certain assets; and appointing a lead independent director.D.

Read the full 740 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE